Madhukar Trivedi
Psychiatry · Dallas, TXNPI 1659333698
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $190,548 of the $209,342 with a category attached, or 91.0%. 13 manufacturers reported payments, led by Otsuka Pharmaceutical Development & Commercialization, Inc. at 34.0% of the total. Reporting peaked in 2019 at $81,444 and has fallen 98.7% since, to $1,080 in 2025. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $1189.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$71K
- Janssen Research & Development, LLC$67K
- Sage Therapeutics, LLC$24K
- Alkermes, Inc.$11K
- Merck$9K
- Biogen$6K
- plus $21K from 7 others
Across 23 payments — averaging $83,363 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alkermes, Inc.$1.6M
- Indivior Inc.$337K
- Janssen Research & Development, LLC$2K
What the payments were for
- Consulting fees$190,54891%
- Speaking & faculty fees$2,2381%
- Travel & lodging$14,3157%
- Food & beverage$2,1811%
- Education$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 65 | $71,216 |
| Janssen Research & Development, LLC | 52 | $66,799 |
| Sage Therapeutics, LLC | 21 | $24,463 |
| Alkermes, Inc. | 5 | $11,023 |
| Merck | 11 | $9,468 |
| Biogen | 3 | $5,508 |
| Otsuka America Pharmaceutical, Inc. | 3 | $4,410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $4,122 |
| Titan Pharmaceuticals, Inc. | 2 | $3,825 |
| Daiichi Sankyo Inc. | 2 | $3,306 |
| Janssen Global Services, LLC | 3 | $2,903 |
| Indivior Inc. | 5 | $2,238 |
| Sunovion Pharmaceuticals Inc. | 1 | $61 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$209,342 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
- Darin OkudaDallas$402K
- Stephen VobachDallas$278K
- Carolyn RekerdresDallas$259K
- Ella DalyDallas$67K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.